Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch - Hydromorphone Mundipharma Retard 16 mg, Retardkapseln | | 70347 | | 03 | | Hydromorphone Mundipharma Retard 16 mg | | Retardkapseln | | N02AA03 | | Hydromorphone | | 18.07.2025 | | |
| Composition | hydromorphoni hydrochloridum 16 mg corresp. hydromorphonum 14.19 mg, cellulosum microcristallinum, hypromellosum, ethylcellulosum, silica colloidalis anhydrica, dibutylis sebacas, Kapselhülle: gelatina, natrii laurilsulfas corresp. natrium 0.012 mg, E 172 (rubrum), E 172 (flavum), E 172 (nigrum), E 171, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, pro capsula. | Packungsbestandteile | | Delayed release capsules | | Active Agent | Dose |
---|
Hydromorphon Hydrochloride | 16 mg correspond Hydromorphone 14.19 mg |
| | Inactive agents | | additional_information |
---|
| | | | | | | | | | | | | | | | | color. | | | color. | | | | Gelatina | | Kapselhülle | Hypromellosum | | | | | Drucktinte | | | | | | | Propylenglycol | | | Silica Colloidalis Anhydrica | | |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
005 | 30 | PR | PR | A+ | | Yes | 006 | 60 | PR | PR | A+ | | Yes |
|
|